High Flow Nasal Therapy in Covid 19 Patient

NCT05094648 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2021-10-26

No results posted yet for this study

Summary

This study aims to To identify factors that predict success of high flow nasal therapy in covid19 patients .

Conditions

  • High Flow Nasal Therapy

Interventions

OTHER

high flow nasal therapy

effect of high flow nasal therapy in covid 19 patients who pass and who need non invasive

Sponsors & Collaborators

  • Maha Mahmoud Ahmed

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-01
Primary Completion
2022-08-31
Completion
2022-09-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05094648 on ClinicalTrials.gov